Cardiff Oncology, Inc.
ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION
Last updated:
Abstract:
Provided is a method of treating benign prostatic hyperplasia (BPH) in a patient. Also provided is a method of inhibiting non-adrenergic contraction of a smooth muscle. Additionally provided is a method of inhibiting proliferation of human prostate cells.
Status:
Application
Type:
Utility
Filling date:
25 Feb 2020
Issue date:
12 May 2022